Latest Articles
‘Significant’ treatment to be discontinued: A patient’s perspective - Royal Australian College of General Practitioners (RACGP)
‘Significant’ treatment to be discontinued: A patient’s perspective Royal Australian College of General Practitioners (RACGP)
Published: June 12, 2026, 4:51 a.m.
Leuprorelin Drugs Market Size, Share, Growth | CAGR of 5.8% - Market.us Media
Leuprorelin Drugs Market Size, Share, Growth | CAGR of 5.8% Market.us Media
Published: June 12, 2026, 12:36 a.m.
Association Between Pre-Conception Surgery for Deep Endometriosis and Adverse Obstetric Outcomes: A Retrospective Cohort Study.
To evaluate whether pre-conception surgery for deep endometriosis (DE) is associated with obstetric outcomes compared with conservative management.
Published: June 12, 2026, midnight
Soroptimist SVG signs MOU to improve health for Girls and Women - SearchLight.vc
Soroptimist SVG signs MOU to improve health for Girls and Women SearchLight.vc
Published: June 11, 2026, 7:04 p.m.
Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis - Inside Precision Medicine
Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis Inside Precision Medicine
Published: June 11, 2026, 6:50 p.m.
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data - TipRanks
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data TipRanks
Published: June 11, 2026, 4:35 p.m.
Lotus Leaf Tea is Believed to Prevent Cysts to PCOS in Women - VOI.id
Lotus Leaf Tea is Believed to Prevent Cysts to PCOS in Women VOI.id
Published: June 11, 2026, 4:05 p.m.
Lotus Leaf Tea is Believed to Prevent Cysts to PCOS in Women - VOI.ID
Lotus Leaf Tea is Believed to Prevent Cysts to PCOS in Women VOI.ID
Published: June 11, 2026, 4:05 p.m.
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates - marketscreener.com
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates marketscreener.com
Published: June 11, 2026, 1:52 p.m.
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis - Quiver Quantitative
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis Quiver Quantitative
Published: June 11, 2026, 11:41 a.m.
Link copied to clipboard!